CRISPR pioneer Feng Zhang launches a ‘limitless’ biotech upstart with big plans for speeding new drug development – Endpoints News
Endpoints News |
CRISPR pioneer Feng Zhang launches a ‘limitless’ biotech upstart with big plans for speeding new drug development
Endpoints News The biotech came out of stealth mode today with a $15.6 million round, which we’ve been tracking, and a plan to employ the CRISPR system with a platform tech built around artificial intelligence, genome sequencing, gene synthesis and screening efforts … Stealth biotech Arbor steps out of the shadows, announcing it’s found a new CRISPR enzymeSTAT Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery PlatformForexTV.com |
Nasdaq |
Inovio’s (INO) Q4 Loss Narrower than Expected, Revenues Beat
Nasdaq Moreover, the company also received additional $1.2 million revenues under Inovio’s prior collaboration with Roche RHHBY for the development of Inovio’s DNA immunotherapy, INO-180. However, upside in revenues was partially offset by lower grants … |
|
Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
GlobeNewswire (press release) CAMBRIDGE, Mass., March 15, 2018 (GLOBE NEWSWIRE) — Arbor Biotechnologies, an early stage life sciences company, today published its first findings of a new member of the CRISPR-Cas13 enzyme family—Cas13d, arising from Arbor’s discovery platform. In … |